hawthorn

Crataegus monogyna, commonly known as rowan or hawthorn, is native to Europe and western Asia. Traditionally, its use has not been extensively documented in specific medical practices; however, it is often employed in herbal medicine for cardiovascular support due to its purported benefits. Scientific evidence suggests that Crataegus monogyna may alleviate some of the adverse effects associated with cisplatin chemotherapy, such as liver enzyme increases and kidney function markers, while preserving tissue structure. While there are limited robust clinical studies supporting its use for anxiolytic or antidepressant effects, preclinical research indicates potential antioxidant properties and inhibition of lipid peroxidation. The bioactive compound content can be enhanced through optimal extraction methods, which may further improve its biological activities. No major safety concerns have been recorded, but as with any herbal supplement, individual responses can vary. There is currently no evidence to suggest significant drug interactions; however, caution should still be exercised when combining Crataegus monogyna with other medications or treatments.

Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.